End TB
Sí, podemos impedir que las patentes obstaculicen el tratamiento de la tuberculosis
Un día antes del Día Mundial de la Tuberculosis, la Oficina de Patentes de la India rechazó la solicitud del gigante farmacéutico Jannsen de prorrogar la patente del medicamento bedaquilina.
Yes, we can stop patents getting in the way of TB treatment
A day ahead of World TB Day, the Indian Patent Office rejected pharma giant Jannsen’s application for a patent extension on drug bedaquiline. If the patent had been extended, public and family budgets would have remained burdened by unjustifiably high costs of the drug
- Brazil approves end to 6×1 work schedule and reduction of the work week to 40 hours
- Israel kills 31 people in Lebanon on the eve of Eid al-Adha
- Israel carries out sixth consecutive Eid massacre in Gaza
- Far-right Janez Janša to return for fourth government term in Slovenia
- With peace deal nearly final, US launches fresh attacks on Iran
